Capturing Parkinson's Disease Medication Side Effects During Daily Activities
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
The purpose of the study is to test whether body-worn wireless motion sensors can measure
 dyskinesias (involuntary movements caused by medications) in individuals with Parkinson
 disease (PD) independent of voluntary activity being performed and other PD motor symptoms
 (e.g. tremor).
Inclusion Criteria:

 -  Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor
 fluctuations that include dyskinesias after taking their usual dose of
 levodopa/carbidopa

 Exclusion Criteria:

 -  Antipsychotic medications (including quetiapine and clozapine)

 -  Coexisting neurologic disease such as stroke or dementia

 -  Lacking capacity for informed consent

 -  Residing in a nursing home

 -  comorbid non-neurologic illnesses that impacts the ability to perform the study tasks

 -  Implantable defibrillators